{"ticker": {"uuid": "5c03ba20-9b97-4e8a-9694-bfae1208f6d8", "symbol": "CU6", "name": "Clarity Pharmaceuticals Ltd", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Clarity Pharmaceuticals (ASX:CU6) Shares Advance While Investors Focus on Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNY0tRSzlvWkkzZ3dycy1SSkhvOW5mUGs0LVRUdDh3bG1rOXQtVG13X04xWkFQQVN5R0YwZDdIMS14VEFfLWJsamt0SE0ySTdYQjRWMU5yTnBOampHWW14OXQ0N3VVTTZUTS1IOWhuV2xmVUNXVGk2ZDhNNkpNbFpLUEQxaHloRm9UbkFQWmdlOXZKa0czMENhc2NNb2ZQaklCU1JwQl9nbHlxcVpPcl9PSVEtdTYtVl9PX1pVQVNGLWRtdjNFZmc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-15T09:53:00+00:00", "published_display": "15 Jul 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clarity Pharmaceuticals (ASX:CU6) Redefining Cancer Treatment Through Its Copper Theranostics Platform?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQRFRFNXU1cVB6ZENQQUNsaFBVQ1JkMlEyNklvRzBFTjNkR0F2VlR1M0xGNWFmM3MtNk5XV0ktQTlGd2JTSmlCdml3a2t4WHV4S25CMksxUXRLR01KWDJKWEpISUg3N3h1bzhZeVd3U09CSjFfTHF3a2lMX3owRkRfQlQxb2ZXaHBKV3hfWjUybkxEd2d1eUptb2F5TGNkdE1fTXYzV0tmc21fbEc0Qy11V2JDajNYaVhldjJmaWFCVWZjbHp5blF3aDZWYlczT1FMUWJDV1dlcFpvbWFyYmJydnRR?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clarity Pharmaceuticals\u2019 (ASX:CU6) Copper Theranostics Pipeline Redefining Its Long-Term Oncology Strategy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T19:41:04+00:00", "published_display": "07 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Rallies Nearly 15%: Is This ASX Healthcare Stock Worth Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQQUxkYTZvV3FBanNTRW05U2RueFZrcm80eElMVlNlczRiaGxNRDFqZ1B5dVVmNGlQTU9kSjgwa0xNRFgxcDdaSlpWazRMRUJ3bkxZLWZWdFNoQXc3RUdiY0JmSDJtWE1MbjhuQnVheFU1R2VKTHpZWFdpVVExZXlmbWNpZFc4N0lYeW9sRUx1YmZFc2J0MnBOc0JnN3gtbGRSRXlqMG5Oa1VDZ29HWVY4b0hEamZFeXRMT2hpV3B5bnRLUFRSNW84c1RiVQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX: CU6 Climbs as Precision Oncology Developer Draws Market Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTlE3MDdxNGdKSFZsT25OQ0owUmkwRk5odExKVTl6WUhzRjNRdWlaVXJ1aDlld3NwOGMzSGU4bDBjMnlCS0NpalhtM3hadzI4a0hjR0hvWU5yalgwLXQxZ3FWSXBBbk5Kc0ZsWmp3elN6SXJSUnVCUEY3ek9aU29sVU5DbW5CN3M5ZDFTUnJuTjhHTmZlcXdvUUxiQnR6bUE4YWlWdnJBWEtrNlVj?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Gains as Radiopharma Stocks Stay Hot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSGg3d21FZ1I0TDdKdFNPdFFzcVZHVFdNMUJLRlhjZGE0UGxKd0VOcmVnemdVc0dUc0k1NktueGFTeEVFUlBfamxUdTFxVEVzVG5wRzYwVS1XVG9vX0MxX3Zqd2hLSXB0M0VhbHM0SmowbXVlV1RmSks2eDEyVGJzcVZyUUV3V2M4YzhhdlRWSFlNQm9qR3Q3WDhfbFkxcjZRcXRLbm5HaGNFZw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Advances Prostate Cancer Research, Shares Gain Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQNDdVNEl1c3ZhdlNoQVZ3TUJZTzJfU2tWOU5ueWFIU25iRzZIREU0eVhVZ2xqUlhIR0h3UkEzbkN3UEpXcWhmQ0loMjRqcGNxS21jTXhTcmItdkdvNXhuajVubmVNU0RvNE55YVBrbDJBcVdHdkctSFo0OVRyWk55clhGS1VXR3c5MmpONE56R05LbFA1R3hQNmctbW1VQlJ0NVZoVHZ0bV9EV0ppZmRVbXpOenZCMUp4M0FMUV9Sclk5SUVsU2Fj?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Shares Close At 52-Week Low: The Latest", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOclBYNUFzU0NhSFlvYUM3X1dwbkRVVktvTFRNdndMTUZDQllpLW9OcnFlX3pMOXZkLTZ6dzlFbHFCWlhJTVZScDRBOHVxX2p3RzhQdjFvNlU4TnVfTG4wbllBeC01ZGdsMGVSSFJkenhDaEM2REJEZEs2aDA1T2R2VUhQVG4tWHNXY2tCWGVXWVNWNG53NUE?oc=5", "source_name": "thebull.com.au", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6): Biotech Stock Falls as Investors Watch Trial Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPVzUwX3dpMGdRMU9WWlJEMm9VRkh4NVRDX3BfVUtZSUZfN1QwS1lXd0NTdVVkaDRIRnlBWFV4bnZxd253alB6NFZrWm8wQ2xLLVVfYl93WnVueTZuVkFwU0NlWnNGeTg0TzBvTjVXblNGN0tBNFd5eGlZYUVMVjAxaDBtR1NrZ0VXQkJHaGNnQlpuTksyeHQxaDFldmpqaGNyR0E4SjdVaHBRTUdfcHduY1NEalYxMjZGUW1YRzBR?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Plunges as Clinical-Stage Biotech Sell-Off Continues", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNY1hVSERXSUF3T2RvaUFMdVRiNHhGQVYyUEhnYkdNUElkeGxldXpkNEhjbjBNUGdxdjdDdHFUb1R0OVhsUHBfbGJ3MXBsdE4xY3o0NWRoUENMU3pUN0hDTFFtNExNR0dHbkNmcnVGb25zS2YzRk83VEh3Y1RESnRUU3FaQjRCR1kzenpqbUhtaUhqZGZEd0dhZ1hhOVNxazRCOXg4U1ZXYmkzVzJEU05sTmZ0QXNIaEhYWkdTXzN1MA?oc=5", "source_name": "Kalkine", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (CU6 ASX: CU6) Rises 9% as Traders Rotate Into Biotech Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNRzBzVUN0MzVnbDdfWnl2aGZhdFJpc1NITHdMcVlzQ1hNSWVyaGdjX1BjQjBfRUk1TkVSZ1dwU1ozejNlajRndlRhcjU3WldTMTNxTjQyRUZrMUxWdkwxSGVrRjFCRWpqejBvbTZGcjNpUGZ5T2d1aFRHa1RNWlU4TWV5bXZZSlY2UGhyUGM0S25rQk1iR2hsWV8xUjk4WW5SMzBvX1VYc0pXNVJUQmVWanFfUmJLS0R1UVVhSw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Limited (ASX:CU6): Biotech Darling Faces a Defining Technical Crossroads", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOV21IWTFoNnhsc3ZZRHp0bUtEZ19feGY2Y1p5OEhSZ3hRUEVUZFpBd2RHV0xYLUc3ZXBzZXNKeTFiMDI2cURCUzhaS19LbTV5RWJQZzd1dHR4aGZnakktU0d4aU44N092dkYwNFlyQ21ZeF9qMnE0QkR1WW9pVVVCcFlFVXB0aEs5YmlmSlNkdGMwU2ZFYm9FejVEU1ZOUXYtSDRRWlR5Mmt1OVE2aDNJeFc3NWdnVjgwMlN0ZW55bWpIX2dhZVFJNUtn?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX: CU6) Advances Amid Oncology Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNRnFMV1M5T3JDQzVBX1FrNDg3b0FnR1VyT3J2SEM3c0hIV1NjbXpBUVhoZ21GbkFFU1lQcVZlWkhUdXVfNDNxMDBYd1VITVY1cjBFUkZ2aXFaYkNvaFFVUUhTYk0xX0VFV3pSNmZHY2Y0NHJibmI2dG1SeVA1bGg4SkJDTDFXVFRjWlA3cFNUZGkxcnVZenpDY0FmWTNKbFdmM0ViS25iS0JBMkhhdTRQTw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trade Alert: CEO, MD & Executive Director Of Clarity Pharmaceuticals Michelle Parker Has Sold Stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clarity Pharmaceuticals shares just fell 5% on today\u2019s announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeUdHWVNlTnZCOWh4cTdwN0ZPd2xVWWhDM0xnLUc3TVdNbDBNaFFIU1dWLVFEQjFwQTUxcDNSZXpBODZSVnNnVEpONnNjcFZuSDdXdkMwbW5iS3FvX0FFaTlZWXhqNmVtVkl3OXZjSWd3OUtOendHa1lhVDk5S1l2UkJLQlM4WDRzUEpfTFhZRkgyRlZTWGpzQnJGc0NEbGRFOEpreFA4MV8?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Clarity Pharmaceuticals' (ASX:CU6) Manufacturing Deal:", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOX3RMLUZtNWFpSkpxSGluZTJqX3JyR2t4UDlaX2d5Wl94SUtULVdxT3JaZDMtVWJjTjBWSFRxZG1xVmp4OVBQYzdoNXlKZTNJdndVVkRTVGVYVDVLc3FPVVVkdmRITDNyLWp3YVBDM01GYV9ubzJEd0RiMGk2S3ZfVmZnVGVJbWhveWlMczF6MlJHaWZhRkdxOUJnRQ?oc=5", "source_name": "Kalkine", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Clarity Pharmaceuticals (ASX:CU6) Stock Surging Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNWDNMZ1JlVm5qRUFvTkh4WVBwcXFMd09idnRreG5xRDhlSEtKeklZaVhWTGxLTHZ1bFg3RnNPQmNBVWxMWUtpMTNIMjdqTENUcHJvc1ZIOTZaN0d0NnRDQV8xZUd0OUVDM1d6TnBnc01DeTBmc2VZenZrMi11MHUxOGZVS3VxbUI1R2tJVm1BcHNYbjBYc3daLTJqM2xTNGM?oc=5", "source_name": "Kalkine", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYTFBN2VTSVZvbml5cTA2V21WUnVRb1cwdm9wdUJCR0syUzdLSjBoZU1rUHNVYzJsVlpWX01DTGZYb25ONHRqYmZzYTVQdjRkai1MSDNWRVVqVU5zX3pzbFlQZVJNSXllaEtOYUo5Skl6UndsRkRwS1ZpMVFlWGRnVExzVVQ2MzhNNDN2cXlwZWF5WmNtaHpUb2VFTHlSNzNJ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Valuation After AMPLIFY Trial Recruitment Surges Past Initial Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxNVGFRcm8zdHFhbnJ1ekxINF9KS2FNU3FfSWc0bmhERnVwdmlJd0Z5MURnMEZSM3o1TG84Mi1sWlN0YTZla2RvamtNVE1ERWxKVVdsS2xOLW1iamZzWEpVQXR6UUx6MkZKdUx5dkJXRkx1bUp2aE1TMW1YQTNXUVN3cDFyQXZpMHFSZW4zaVFITldBMUk1UVFsaXhBQW16U19nVVBqYWdoYzU2RHpJMXlzcjFpOGE3VTQwcjc2ckhTRXpJSFA1UDRLMHJSSkVQX2l3ZG1zdHU3cmo2dW1jbTFWenQ2bnUxQUlCZTV2MVNLNmoxUdIB9wFBVV95cUxQUUpZRWZDRF9RckZOTjlvT2pvaHlvc2tzTGF1QXpjTEhLV1ozZ0hCX1JPeVNGLW1odURsU3JXdlZuWWZUdl9vWUhCaWx2NjhhSXljUG03REVPVzhJMWQwcG9xWEVhRVBhcXZ2OEVCSDBFaEduazVHOTBGSmUzZ1lIWm9rVjJ2ME0xMEd1Qk0yOVVvSjlUWHV1Y0JleXA5S2xDMUdtdGVkZ0prdjk4V0I3UzlRNERCQXVTVzdxVzA4czYtVFBpcU9CVHgwVkNLUk54a2JKY21aMzhBbjJrdVVWX0RrTHFkZTRBOWtCVjM3S1Z0X3hkUWE4?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals H1 2026 Loss Worsening Challenges Bullish Profitability Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clarity Pharmaceuticals, EOS, Nuix, and Reece shares are racing higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPS2R0Q1FONE9pQ2J0UHE4cjBzVmd5ZHhOb3NBc0VCd0ZTUTZScGhRR3dGblZrc2IxRjU2LWNnWUozT3c1WFBSOEQ2ZkxEVTVzMjhVZDZJdDBLM3NwclI1cW5lRGZEZmwxc2s5eG1feGtoLVZBTlpORC1PQzJQOTJpRE9ZM0MzZERYc1hnZy1DVW1Vc29TQThFWmhkX243WVBpcG1sNy1VazBHNFdhNkNJWnMzWQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit as were institutions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 4DMedical, Amaero, Clarity Pharmaceuticals, and Treasury Wine shares are falling today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQamtsX1VMOG1tMTFxV195eGNBaktHS0JUWFozREdDdGJFRVJIUUhzYVNwcGJnQ0dabDdjcl9WeW9COV9GdzFHaThLaml3Rl9aeTZfOUhPOEVkNk1OZ05odWtZeFd1WWlpUGZHRE9Jc0NMM1BvVUZLT0l0cWZ5TC05TjFvZW96NVA0X3pYd3B1RUt5WGJBaFo2SFFaNE1rQjRSN3RwMkcxbU9QbThSb3paSW5nUGRSUlZrZzlHQmVkdXE?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Clarity Pharmaceuticals Ltd (ASX:CU6)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE12RjVobFlnb0hseVdQWnJEWm1hMTAwR3BKb1ZwSk5LRDJvU3I0MFRGUDhzQmF4SDlNYk5pTDlKeGgzY3VJR1NRSXlUNWZGaUFo?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:46:54+00:00", "published_display": "30 Oct 2025 15:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd (ASX:CU6) Is Expected To Breakeven In The Near Future", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUXh1bDlRcFphdnZweU1ScUpvNHZDMkNPM3RGUmZPcDlvRHN4cnd4QWlzcmJqYmxBNkJ6elIybUtnV3FDdjkwZE1WUGpsbkdJMmVzZGFuYVlOWHp1YjlIaG5ZT0EzeW9aWXZIUUV3LVNOd1YyOHlhMzFGcDJMc0wxUDUxTXFUeFRa?oc=5", "source_name": "Market source", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Clarity Pharmaceuticals (ASX:CU6) Shares Advance While Investors Focus on Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNY0tRSzlvWkkzZ3dycy1SSkhvOW5mUGs0LVRUdDh3bG1rOXQtVG13X04xWkFQQVN5R0YwZDdIMS14VEFfLWJsamt0SE0ySTdYQjRWMU5yTnBOampHWW14OXQ0N3VVTTZUTS1IOWhuV2xmVUNXVGk2ZDhNNkpNbFpLUEQxaHloRm9UbkFQWmdlOXZKa0czMENhc2NNb2ZQaklCU1JwQl9nbHlxcVpPcl9PSVEtdTYtVl9PX1pVQVNGLWRtdjNFZmc?oc=5", "source_name": "Kalkine", "published_at": "2026-07-15T09:53:00+00:00", "published_display": "15 Jul 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clarity Pharmaceuticals (ASX:CU6) Redefining Cancer Treatment Through Its Copper Theranostics Platform?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQRFRFNXU1cVB6ZENQQUNsaFBVQ1JkMlEyNklvRzBFTjNkR0F2VlR1M0xGNWFmM3MtNk5XV0ktQTlGd2JTSmlCdml3a2t4WHV4S25CMksxUXRLR01KWDJKWEpISUg3N3h1bzhZeVd3U09CSjFfTHF3a2lMX3owRkRfQlQxb2ZXaHBKV3hfWjUybkxEd2d1eUptb2F5TGNkdE1fTXYzV0tmc21fbEc0Qy11V2JDajNYaVhldjJmaWFCVWZjbHp5blF3aDZWYlczT1FMUWJDV1dlcFpvbWFyYmJydnRR?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clarity Pharmaceuticals\u2019 (ASX:CU6) Copper Theranostics Pipeline Redefining Its Long-Term Oncology Strategy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T19:41:04+00:00", "published_display": "07 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Rallies Nearly 15%: Is This ASX Healthcare Stock Worth Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQQUxkYTZvV3FBanNTRW05U2RueFZrcm80eElMVlNlczRiaGxNRDFqZ1B5dVVmNGlQTU9kSjgwa0xNRFgxcDdaSlpWazRMRUJ3bkxZLWZWdFNoQXc3RUdiY0JmSDJtWE1MbjhuQnVheFU1R2VKTHpZWFdpVVExZXlmbWNpZFc4N0lYeW9sRUx1YmZFc2J0MnBOc0JnN3gtbGRSRXlqMG5Oa1VDZ29HWVY4b0hEamZFeXRMT2hpV3B5bnRLUFRSNW84c1RiVQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX: CU6 Climbs as Precision Oncology Developer Draws Market Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTlE3MDdxNGdKSFZsT25OQ0owUmkwRk5odExKVTl6WUhzRjNRdWlaVXJ1aDlld3NwOGMzSGU4bDBjMnlCS0NpalhtM3hadzI4a0hjR0hvWU5yalgwLXQxZ3FWSXBBbk5Kc0ZsWmp3elN6SXJSUnVCUEY3ek9aU29sVU5DbW5CN3M5ZDFTUnJuTjhHTmZlcXdvUUxiQnR6bUE4YWlWdnJBWEtrNlVj?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Gains as Radiopharma Stocks Stay Hot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSGg3d21FZ1I0TDdKdFNPdFFzcVZHVFdNMUJLRlhjZGE0UGxKd0VOcmVnemdVc0dUc0k1NktueGFTeEVFUlBfamxUdTFxVEVzVG5wRzYwVS1XVG9vX0MxX3Zqd2hLSXB0M0VhbHM0SmowbXVlV1RmSks2eDEyVGJzcVZyUUV3V2M4YzhhdlRWSFlNQm9qR3Q3WDhfbFkxcjZRcXRLbm5HaGNFZw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Advances Prostate Cancer Research, Shares Gain Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQNDdVNEl1c3ZhdlNoQVZ3TUJZTzJfU2tWOU5ueWFIU25iRzZIREU0eVhVZ2xqUlhIR0h3UkEzbkN3UEpXcWhmQ0loMjRqcGNxS21jTXhTcmItdkdvNXhuajVubmVNU0RvNE55YVBrbDJBcVdHdkctSFo0OVRyWk55clhGS1VXR3c5MmpONE56R05LbFA1R3hQNmctbW1VQlJ0NVZoVHZ0bV9EV0ppZmRVbXpOenZCMUp4M0FMUV9Sclk5SUVsU2Fj?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Shares Close At 52-Week Low: The Latest", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOclBYNUFzU0NhSFlvYUM3X1dwbkRVVktvTFRNdndMTUZDQllpLW9OcnFlX3pMOXZkLTZ6dzlFbHFCWlhJTVZScDRBOHVxX2p3RzhQdjFvNlU4TnVfTG4wbllBeC01ZGdsMGVSSFJkenhDaEM2REJEZEs2aDA1T2R2VUhQVG4tWHNXY2tCWGVXWVNWNG53NUE?oc=5", "source_name": "thebull.com.au", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6): Biotech Stock Falls as Investors Watch Trial Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPVzUwX3dpMGdRMU9WWlJEMm9VRkh4NVRDX3BfVUtZSUZfN1QwS1lXd0NTdVVkaDRIRnlBWFV4bnZxd253alB6NFZrWm8wQ2xLLVVfYl93WnVueTZuVkFwU0NlWnNGeTg0TzBvTjVXblNGN0tBNFd5eGlZYUVMVjAxaDBtR1NrZ0VXQkJHaGNnQlpuTksyeHQxaDFldmpqaGNyR0E4SjdVaHBRTUdfcHduY1NEalYxMjZGUW1YRzBR?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX:CU6) Plunges as Clinical-Stage Biotech Sell-Off Continues", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNY1hVSERXSUF3T2RvaUFMdVRiNHhGQVYyUEhnYkdNUElkeGxldXpkNEhjbjBNUGdxdjdDdHFUb1R0OVhsUHBfbGJ3MXBsdE4xY3o0NWRoUENMU3pUN0hDTFFtNExNR0dHbkNmcnVGb25zS2YzRk83VEh3Y1RESnRUU3FaQjRCR1kzenpqbUhtaUhqZGZEd0dhZ1hhOVNxazRCOXg4U1ZXYmkzVzJEU05sTmZ0QXNIaEhYWkdTXzN1MA?oc=5", "source_name": "Kalkine", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (CU6 ASX: CU6) Rises 9% as Traders Rotate Into Biotech Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNRzBzVUN0MzVnbDdfWnl2aGZhdFJpc1NITHdMcVlzQ1hNSWVyaGdjX1BjQjBfRUk1TkVSZ1dwU1ozejNlajRndlRhcjU3WldTMTNxTjQyRUZrMUxWdkwxSGVrRjFCRWpqejBvbTZGcjNpUGZ5T2d1aFRHa1RNWlU4TWV5bXZZSlY2UGhyUGM0S25rQk1iR2hsWV8xUjk4WW5SMzBvX1VYc0pXNVJUQmVWanFfUmJLS0R1UVVhSw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Limited (ASX:CU6): Biotech Darling Faces a Defining Technical Crossroads", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOV21IWTFoNnhsc3ZZRHp0bUtEZ19feGY2Y1p5OEhSZ3hRUEVUZFpBd2RHV0xYLUc3ZXBzZXNKeTFiMDI2cURCUzhaS19LbTV5RWJQZzd1dHR4aGZnakktU0d4aU44N092dkYwNFlyQ21ZeF9qMnE0QkR1WW9pVVVCcFlFVXB0aEs5YmlmSlNkdGMwU2ZFYm9FejVEU1ZOUXYtSDRRWlR5Mmt1OVE2aDNJeFc3NWdnVjgwMlN0ZW55bWpIX2dhZVFJNUtn?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals (ASX: CU6) Advances Amid Oncology Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNRnFMV1M5T3JDQzVBX1FrNDg3b0FnR1VyT3J2SEM3c0hIV1NjbXpBUVhoZ21GbkFFU1lQcVZlWkhUdXVfNDNxMDBYd1VITVY1cjBFUkZ2aXFaYkNvaFFVUUhTYk0xX0VFV3pSNmZHY2Y0NHJibmI2dG1SeVA1bGg4SkJDTDFXVFRjWlA3cFNUZGkxcnVZenpDY0FmWTNKbFdmM0ViS25iS0JBMkhhdTRQTw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trade Alert: CEO, MD & Executive Director Of Clarity Pharmaceuticals Michelle Parker Has Sold Stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clarity Pharmaceuticals shares just fell 5% on today\u2019s announcement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeUdHWVNlTnZCOWh4cTdwN0ZPd2xVWWhDM0xnLUc3TVdNbDBNaFFIU1dWLVFEQjFwQTUxcDNSZXpBODZSVnNnVEpONnNjcFZuSDdXdkMwbW5iS3FvX0FFaTlZWXhqNmVtVkl3OXZjSWd3OUtOendHa1lhVDk5S1l2UkJLQlM4WDRzUEpfTFhZRkgyRlZTWGpzQnJGc0NEbGRFOEpreFA4MV8?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Clarity Pharmaceuticals' (ASX:CU6) Manufacturing Deal:", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOX3RMLUZtNWFpSkpxSGluZTJqX3JyR2t4UDlaX2d5Wl94SUtULVdxT3JaZDMtVWJjTjBWSFRxZG1xVmp4OVBQYzdoNXlKZTNJdndVVkRTVGVYVDVLc3FPVVVkdmRITDNyLWp3YVBDM01GYV9ubzJEd0RiMGk2S3ZfVmZnVGVJbWhveWlMczF6MlJHaWZhRkdxOUJnRQ?oc=5", "source_name": "Kalkine", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Clarity Pharmaceuticals (ASX:CU6) Stock Surging Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNWDNMZ1JlVm5qRUFvTkh4WVBwcXFMd09idnRreG5xRDhlSEtKeklZaVhWTGxLTHZ1bFg3RnNPQmNBVWxMWUtpMTNIMjdqTENUcHJvc1ZIOTZaN0d0NnRDQV8xZUd0OUVDM1d6TnBnc01DeTBmc2VZenZrMi11MHUxOGZVS3VxbUI1R2tJVm1BcHNYbjBYc3daLTJqM2xTNGM?oc=5", "source_name": "Kalkine", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYTFBN2VTSVZvbml5cTA2V21WUnVRb1cwdm9wdUJCR0syUzdLSjBoZU1rUHNVYzJsVlpWX01DTGZYb25ONHRqYmZzYTVQdjRkai1MSDNWRVVqVU5zX3pzbFlQZVJNSXllaEtOYUo5Skl6UndsRkRwS1ZpMVFlWGRnVExzVVQ2MzhNNDN2cXlwZWF5WmNtaHpUb2VFTHlSNzNJ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Valuation After AMPLIFY Trial Recruitment Surges Past Initial Target", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals H1 2026 Loss Worsening Challenges Bullish Profitability Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clarity Pharmaceuticals, EOS, Nuix, and Reece shares are racing higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPS2R0Q1FONE9pQ2J0UHE4cjBzVmd5ZHhOb3NBc0VCd0ZTUTZScGhRR3dGblZrc2IxRjU2LWNnWUozT3c1WFBSOEQ2ZkxEVTVzMjhVZDZJdDBLM3NwclI1cW5lRGZEZmwxc2s5eG1feGtoLVZBTlpORC1PQzJQOTJpRE9ZM0MzZERYc1hnZy1DVW1Vc29TQThFWmhkX243WVBpcG1sNy1VazBHNFdhNkNJWnMzWQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit as were institutions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 4DMedical, Amaero, Clarity Pharmaceuticals, and Treasury Wine shares are falling today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQamtsX1VMOG1tMTFxV195eGNBaktHS0JUWFozREdDdGJFRVJIUUhzYVNwcGJnQ0dabDdjcl9WeW9COV9GdzFHaThLaml3Rl9aeTZfOUhPOEVkNk1OZ05odWtZeFd1WWlpUGZHRE9Jc0NMM1BvVUZLT0l0cWZ5TC05TjFvZW96NVA0X3pYd3B1RUt5WGJBaFo2SFFaNE1rQjRSN3RwMkcxbU9QbThSb3paSW5nUGRSUlZrZzlHQmVkdXE?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Clarity Pharmaceuticals Ltd (ASX:CU6)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE12RjVobFlnb0hseVdQWnJEWm1hMTAwR3BKb1ZwSk5LRDJvU3I0MFRGUDhzQmF4SDlNYk5pTDlKeGgzY3VJR1NRSXlUNWZGaUFo?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:46:54+00:00", "published_display": "30 Oct 2025 15:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarity Pharmaceuticals Ltd (ASX:CU6) Is Expected To Breakeven In The Near Future", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUXh1bDlRcFphdnZweU1ScUpvNHZDMkNPM3RGUmZPcDlvRHN4cnd4QWlzcmJqYmxBNkJ6elIybUtnV3FDdjkwZE1WUGpsbkdJMmVzZGFuYVlOWHp1YjlIaG5ZT0EzeW9aWXZIUUV3LVNOd1YyOHlhMzFGcDJMc0wxUDUxTXFUeFRa?oc=5", "source_name": "Market source", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 26, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 21, "score": 51, "total": 26, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 13.2, "count": 24}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 2.41, "latest_week": "2026-07-10", "one_week_move": 9.0, "four_week_move": 12.1, "twelve_week_move": -23.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.991307, "market_dynamics_buy_signal": false, "relative_strength": -29.392797, "fair_value_gap": -30.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.0275, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.0% over one week, +12.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 11}, {"label": "simplywall.st", "count": 6}, {"label": "The Motley Fool Australia", "count": 4}, {"label": "Kalkine Media", "count": 2}, {"label": "thebull.com.au", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 26}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "26", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+9.0% over one week, +12.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Clarity Pharmaceuticals (ASX:CU6) Shares Advance While Investors Focus on Pipeline Progress"}], "updated_at": "2026-07-17T09:16:51.103757+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}